ERBB2 and breast carcinoma: The CYP enzymes are also implicated in the metabolism of tamoxifen [21] and bioactivation of lapatinib [22], used in the treatment of hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2)‐positive breast cancers respectively.